Oct. 1, 2021– The federal government has taken dramatic action to get drug companies to restore 340B pricing for outpatient prescription drugs dispensed by community pharmacies to patients of 340B hospitals. On Sept. 22, the Health Resources & Services Administration (HRSA) sent letters to six drugmakers informing them that the agency is asking the Office of Inspector … [Read more...]
The Human Toll of Drug Company Restrictions on 340B
May 26, 2021– Anne Webster knew last fall how bad things would get for many of her patients when the drug company Eli Lilly unilaterally pulled out of offering discounts through the 340B drug pricing program on medications dispensed at community pharmacies. As the nurse practitioner at the endocrinology clinic for UnityPoint Health Methodist in Peoria, Ill., she cares for many … [Read more...]
New Federal 340B Order Is Major Step Toward Restoring Drug Discounts
May 19, 2021– The Health Resources & Services Administration (HRSA) has taken decisive action to put a stop to the actions of six drug companies that are denying 340B drug pricing program discounts for medications dispensed at community pharmacies. The action could lead to the end of a nearly year-long dispute pitting for-profit pharmaceutical companies against nonprofit … [Read more...]
The 340B Program Has a New Podcast
May 18, 2020— If your job requires you to keep up to date on the latest developments in the 340B drug pricing program, 340B Health has a new podcast designed to keep you informed and in touch with the nation’s top 340B experts. 340B Insight launched today featuring an exclusive interview with Rear Admiral Krista Pedley, the leader of the government agency that oversees the … [Read more...]
No Fooling: Drug Maker 340B Price Transparency Has Improved
April 1, 2020– The first of April is an opportunity for people to play good-natured pranks on their family and friends. But this year it also gives hospitals participating in the 340B drug pricing program a chance to reflect on something that is definitely not a joke – drug manufacturer pricing transparency has improved because of a federal website that went live a year ago … [Read more...]
340B Hospitals are Key to the COVID-19 Response
March 30, 2020 - As the nation battles the COVID-19 pandemic, 340B hospitals are playing a major role in providing care to all patients, especially those living with low incomes and those in rural communities that traditionally have been underserved. 340B hospitals are on the front lines of this response. Lawmakers in Washington recognize the importance of these hospitals … [Read more...]
Unity of Purpose Brings Together Our Nation’s 340B Care Providers
by Maureen Testoni July 31, 2019 – As I looked out over the veritable sea of attendees during my opening address at the 23rd Annual 340B Coalition Summer Conference, I was filled with respect and gratitude for the shared mission of all who attended. Each in our own way is focused on helping patients in need who rely on the assistance that only the 340B drug pricing program can … [Read more...]